Tag: Genetic Technologies Limited (NASDAQ: GENE)

Business

Genetic Technologies Limited (NASDAQ: GENE) Releases Quarterly Update After Acquiring EasyDNA

Genetic Technologies Limited (NASDAQ: GENE) recently released its quarterly business update to the market. The company is known as a global leader in Genomics-based wellness, health, and serious disease tests. Commercializing the company’s products According to Genetic Technologies CEO Simon Morris, the company is moving swiftly into the commercialization of […]

Business

Genetic Technologies Limited (NASDAQ: GENE) Gains 9% Following Award of Pharmacogenomic Patent

Genetic Technologies Limited (NASDAQ: GENE) jumped 9.13% after the company received a US Patent No. 11,031,098 – ‘Computer Systems and Methods for Genomic Analysis.’ The patent builds on a previously issued patent. The genomics and AI-driven preventive health company had filed the patent application in 2016, expanding on a patent […]